RT Journal Article
SR Electronic
T1 CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e000847
DO 10.1136/jitc-2020-000847
VO 8
IS 2
A1 Lai, Anne Y
A1 Sorrentino, Jessica A
A1 Dragnev, Konstantin H
A1 Weiss, Jared M
A1 Owonikoko, Taofeek K
A1 Rytlewski, Julie A
A1 Hood, Jill
A1 Yang, Zhao
A1 Malik, Rajesh K
A1 Strum, Jay C
A1 Roberts, Patrick J
YR 2020
UL http://jitc.bmj.com/content/8/2/e000847.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.